Gastric Cancer Immune Microenvironment Score Predicts Neoadjuvant Chemotherapy Efficacy and Prognosis

Investigators verified the predictive value of tumor-infiltrating immune cells on the treatment response to neoadjuvant chemotherapy (NACT) and the prognosis of patients with advanced gastric cancer, and explored the impact of NACT on the tumor immune microenvironment.